Overview
Arteriosclerosis affecting coronary artery bypass grafts (CABG) refers to the progressive narrowing and hardening of these grafts, often due to intimal hyperplasia and atherosclerosis, compromising graft patency and coronary blood flow 1.Diagnosis
Endoscopic or angiographic assessment: Essential for visualizing graft patency and identifying stenotic lesions 1.
Coronary angiography: Gold standard for evaluating graft patency and assessing for restenosis or occlusion 1.
Invasive pressure measurements: Can help identify hemodynamic changes indicative of graft dysfunction 1.Management
Revascularization procedures: Redo CABG or percutaneous interventions (e.g., angioplasty, stenting) for significant graft occlusions 1.
Antiplatelet therapy: Use of aspirin or clopidogrel to reduce thrombotic events (specific dosing not detailed in abstracts) 1.
Statins: To manage lipid levels and potentially slow atherosclerosis progression (specific dosing not detailed in abstracts) 1.Special Populations
Elderly: Graft arteriosclerosis may progress more rapidly; close monitoring and tailored revascularization strategies are crucial 1.Key Recommendations
Utilize PTFE graft protection for saphenous vein grafts to mitigate early morphological changes and improve graft integrity (Evidence: Moderate) 1.
Regular angiographic surveillance is recommended for patients with suspected graft dysfunction to early detect and manage complications (Evidence: Expert opinion) 1.
Consider antiplatelet and statin therapy to reduce thrombotic risk and manage atherosclerotic progression in patients with graft arteriosclerosis (Evidence: Moderate) 1.References
1 Kurdal AT, Ustundag N, Güven A, Iskesen I, Bozkurt K, Sirin BH. Protection of saphenous vein graft from arterial pressure: an experimental study. The Thoracic and cardiovascular surgeon 2009. link